In this episode, Alina Sturdza, Radiation Oncologist, shares her perspective on pivotal developments in radiation oncology ...

On January 12, NP-G2-044 (Prilukae), a novel oral fascin inhibitor earned ODD for the treatment of pancreatic cancer. This designation covers the use of the agent as monotherapy and in combination ...

Healio will present its fifth annual Disruptive Innovators Awards for oncology/hematology this spring.Individuals who have ...

Conferences can be an excellent way to connect with fellow oncologists and stay informed on the latest research. These events are key to providing ...

An introduction to the 2026 Oncology Nurse Advisor Summit and links to review the agenda and register to attend this year’s virtual event.

Community Health Media launches an unscripted breast oncology podcast with global KOLs, featuring candid expert ...

Uniphar will act as the exclusive distributor for Lymphir in designated European territories.

Under terms announced in December, Cencora acquired shares in OneOncology from TPG and other shareholders for approximately ...

TrialRelay™, powered by the TrialRouter™ AI agent, replaces passive networks with active orchestration for physician-to-physician handoffs.

This article is authored by Mohan Jain, director, Naprod Life Sciences Pvt. Ltd.

Learn how radiopharmaceuticals are transforming cancer treatment and creating new opportunities for biotech and pharma ...

Tuesday, Feb. 3, is the 11th annual National Women Physicians Day — a day that honors female physicians breaking barriers in ...